SCHEMBL130746

SCHEMBL130746

CC(C)C1(O)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23790310 0.90 OPRM1 (0.36)
SCHEMBL17487274 0.87 OPRM1 (0.35)
SCHEMBL13623179 0.87 OPRM1 (0.35)
SCHEMBL941164 0.87 OPRM1 (0.35)
SCHEMBL2295003 0.86
SCHEMBL2292865 0.86
SCHEMBL1414825 0.83 OPRM1 (0.36)
SCHEMBL18268918 0.83 OPRM1 (0.36)
SCHEMBL17487284 0.83 OPRM1 (0.36)
SCHEMBL7972505 0.83 OPRM1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129116-A1 CYCLOPROPANOL AS A BIOORTHOGONAL WARHEAD FOR ELECTROCHEMICALLY CONTROLLED BIOCONJUGATION APPLICATIONS UNIVERSITY OF SOUTH CAROLINA 2025-04-24 US claimed
CN-115322100-A Delta, epsilon-alkenyl ketone compound and preparation method and application thereof 南京工业大学 2022-11-11 CN claimed
US-20260118361-A1 FLUOROGENIC BIOCONJUGATION OF CYCLOPROPANOL-BASED FLUOROPHORES FOR BIOLOGICAL APPLICATIONS UNIV SOUTH CAROLINA (US) 2026-04-30 US disclosed
US-12391802-B2 Method of forming semicrystalline polyetherimide, and polyetherimide-containing composition SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2025-08-19 US disclosed
US-20250129116-A1 CYCLOPROPANOL AS A BIOORTHOGONAL WARHEAD FOR ELECTROCHEMICALLY CONTROLLED BIOCONJUGATION APPLICATIONS UNIVERSITY OF SOUTH CAROLINA 2025-04-24 US disclosed
US-20230357179-A1 RAF KINASE INHIBITORS AND METHODS OF USE THEREOF DECIPHERA PHARMACEUTICALS, LLC 2023-11-09 US disclosed
US-20230303530-A1 COMPOUNDS AS NUCLEAR TRANSPORT MODULATORS AND USES THEREOF XWPharma Ltd. (KY) 2023-09-28 US disclosed
US-11767313-B2 Compounds as nuclear transport modulators and uses thereof XWPharma Ltd. (KY) 2023-09-26 US disclosed
CN-115322100-A Delta, epsilon-alkenyl ketone compound and preparation method and application thereof 南京工业大学 2022-11-11 CN disclosed
US-20220162387-A1 METHOD OF FORMING SEMICRYSTALLINE POLYETHERIMIDE, AND POLYETHERIMIDECONTAINING COMPOSITION SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2022-05-26 US disclosed
CN-113748155-A Methods of forming semi-crystalline polyetherimides and compositions comprising polyetherimides 高新特殊工程塑料全球技术有限公司 2021-12-03 CN disclosed
WO-2008137779-A2 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2008-11-13 WO disclosed
EP-1982986-A1 PYRROLOPYRIDAZINONE COMPOUND Ube Industries, Ltd. (JP) 2008-10-22 EP disclosed
US-20080207666-A1 Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators MERCK SHARP & DOHME CORP. 2008-08-28 US disclosed
US-20080119407-A1 Vitamin D Receptor Modulators ELI LILLY AND COMPANY 2008-05-22 US disclosed
US-7312334-B2 Method of preparing inhibitors phosphodiesterase-4 MERCK & CO. INC. (US) 2007-12-25 US disclosed
US-7232642-B2 Chemically amplified positive resist composition, a haloester derivative and a process for producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-06-19 US disclosed
WO-2007023281-A2 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2007-03-01 WO disclosed
WO-2007023281-A2 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2007-03-01 WO disclosed
US-20040102472-A1 Method of preparing inhibitors of phosphodiesterase-4 MERCK & CO., INC. 2004-05-27 US disclosed